Current Adjuvant and Targeted Therapies for Pancreatic Adenocarcinoma

E-ISSN： 1875-533x|15|17|1674-1683

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.15, Iss.17, 2008-07, pp. : 1674-1683

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Monoclonal Antibody Therapies Targeting Pancreatic Ductal Adenocarcinoma

Current Drug Discovery Technologies, Vol. 3, Iss. 4, 2006-12 ,pp. : 231-243

Bentham Science Publishers

Access to resources Recommend Favorite

Targeted Therapies for Gastric Cancer: Current Status

By Yoong Jaclyn

Drugs, Vol. 71, Iss. 11, 2011-07 ,pp. : 1367-1384

Adis International

Access to resources Recommend Favorite

Current Status of Targeted Therapies for Mantle Cell Lymphoma

By Chang Julie E. Kahl Brad S.

Drugs, Vol. 71, Iss. 17, 2011-12 ,pp. : 2307-2326

Adis International

Access to resources Recommend Favorite

Pancreatic Adenocarcinoma

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 5, Iss. 10, 2007-11 ,pp. : 998-998

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Current Systemic Treatment and Emerging Therapeutic Strategies in Pancreatic Adenocarcinoma

Current Clinical Pharmacology, Vol. 10, Iss. 4, 2015-10 ,pp. : 256-266

Bentham Science Publishers

Access to resources Recommend Favorite